EMA Dismisses Claims That RWD Is The ‘Wrong Remedy’ For Drug Development Challenges

 
• By Neena Brizmohun
  
drug approval
The EMA says medicines evaluation and regulatory decision making considers all available evidence and its strengths and limitations • Source: Shutterstock

More from Europe

More from Geography